Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate OptimizeRx Corporation before investing.

In this article, we go over a few key elements for understanding OptimizeRx Corporation’s stock price such as:

• OptimizeRx Corporation’s current stock price and volume
• Why OptimizeRx Corporation’s stock price changed recently
• Upgrades and downgrades for OPRX from analysts
• OPRX’s stock price momentum as measured by its relative strength

About OptimizeRx Corporation (OPRX)

Before we jump into OptimizeRx Corporation’s stock price, history, target price and what caused it to recently rise, let’s take a look at some background.

OptimizeRx Corporation operates as a digital healthcare technology company. It offers Dynamic Audience Activation Platform, which generates dynamic audiences with predictive analytics through machine learning methods; Micro-Neighborhood Targeting, which creates consumer audiences using a privacy-first process; Profiler, which provides insights into its customers’ target consumers; banner messages, including brand messaging, therapeutic support messaging, affordability messaging, limited distribution drug information, and patient support program messaging through healthcare professionals; and media execution solutions, which deliver messages through consumer omnichannel network, including through programmatic display, programmatic connected television/over-the-top, programmatic social media, addressable television, digital out-of-home, programmatic audio, and email/direct mail. The company also offers pharmacy alerts, which flag pharmacies that have prescription medications in stock; and financial messaging solutions, which provide prescribers visibility to branded copay offers for patients directly within electronic health record systems and ePrescribing platforms. The company was founded in 2006 and is headquartered in Waltham, Massachusetts.

Want to learn more about OptimizeRx Corporation’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about OptimizeRx Corporation.

What Caused OptimizeRx Corporation Stock’s Price to Rise?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of April 30, 2026, there were 0 analysts who downgraded OptimizeRx Corporation’s stock and 3 analysts who upgraded over the last month.

Additionally, you'll want to evaluate OptimizeRx Corporation’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on OptimizeRx Corporation’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

OptimizeRx Corporation’s current valuation based on AAII’s Value Grade is a B, which means it is considered to be Value.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about OptimizeRx Corporation (OPRX) by visiting AAII Stock Evaluator.

Relative Price Strength of OptimizeRx Corporation

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of April 30, 2026, OptimizeRx Corporation has a weighted four-quarter relative price strength of -13.00%, which translates to a Momentum Score of 19 and is considered to be Very Weak.

Want to learn more about how OptimizeRx Corporation is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

OptimizeRx Corporation Stock Price: Bottom Line

As of May 1, 2026, OptimizeRx Corporation’s stock price is $6.465, which is up 3.77% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like OptimizeRx Corporation stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.